» Articles » PMID: 29960958

Ectopic Insulinomas in the Pelvis Secondary to Rectum Neuroendocrine Tumour

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2018 Jul 2
PMID 29960958
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We describe a middle-aged woman with recurrent hypoglycaemia, who confirmed with rectum G1 neuroendocrine tumour (NET) 6 years ago. Biochemical assay showed high concentration of serum insulin and C-peptide associated with hypoglycaemia. Because of recurrent hypoglycaemia in June 2015, she underwent a resection of the tail of the pancreas. However, hypoglycaemia attack happened more frequently and severely. Ga-DOTA-NOC positron emission tomography/CT revealed five foci in the pelvis with intense uptake. Immediately after excision of the pelvic lesions, insulin and C-peptide decreased to normal levels promptly, and therefore, serum glucose increased significantly. Hypoglycaemia was disappeared, and insulin and C-peptide were normal at 2 years follow-up after surgery. Immunohistochemistry validated the primary rectum NET and pelvic tumours expressed with higher insulin, somatostatin receptor and glucagon-like peptide-1. This is the first reported ectopic pelvic insulinomas secondary to rectum NET, which may originate both from neuroendocrine cells in the rectum and pelvic tissues.

Citing Articles

Ectopic insulinoma: a systematic review.

Guerrero-Perez F, Vilarrasa N, Huanuco L, Busquets J, Secanella L, Vercher-Conejero J Rev Endocr Metab Disord. 2023; 24(6):1135-1146.

PMID: 37434098 DOI: 10.1007/s11154-023-09824-2.


A case report on a protracted course of a hidden insulinoma.

Mohamed Shah F, Mohamad A, Zainordin N, Eddy Warman N, Hatta S, Abdul Ghani R Ann Med Surg (Lond). 2021; 64:102240.

PMID: 33868680 PMC: 8040123. DOI: 10.1016/j.amsu.2021.102240.


Successful surgical treatment of a patient with primary insulinoma of the liver.

Kriger A, Berelavichus S, Gorin D, Galkin G, Yukina M, Ilovayskaya I J Surg Case Rep. 2021; 2020(12):rjaa519.

PMID: 33391648 PMC: 7769218. DOI: 10.1093/jscr/rjaa519.


Ectopic insulinoma: case report.

Sun M, Luo Y, You Y, Han X, Zhao Y BMC Surg. 2019; 19(1):197.

PMID: 31852474 PMC: 6921582. DOI: 10.1186/s12893-019-0661-y.

References
1.
Dimitriadis G, Weickert M, Randeva H, Kaltsas G, Grossman A . Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2016; 23(9):R423-36. DOI: 10.1530/ERC-16-0200. View

2.
Kaltsas G, Michael Besser G, Grossman A . The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004; 25(3):458-511. DOI: 10.1210/er.2003-0014. View

3.
Ramkumar S, Dhingra A, Jyotsna V, Ganie M, Das C, Seth A . Ectopic insulin secreting neuroendocrine tumor of kidney with recurrent hypoglycemia: a diagnostic dilemma. BMC Endocr Disord. 2014; 14:36. PMC: 4046058. DOI: 10.1186/1472-6823-14-36. View

4.
Nisar P, Zaitoun A, Lobo D, Rowlands B . Heterotopic pancreas in the spleen: malignant degeneration to mucinous cystadenocarcinoma. Eur J Gastroenterol Hepatol. 2002; 14(7):793-6. DOI: 10.1097/00042737-200207000-00015. View

5.
de Groot J, Rikhof B, van Doorn J, Bilo H, Alleman M, Honkoop A . Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer. 2007; 14(4):979-93. DOI: 10.1677/ERC-07-0161. View